Variables | Control (n = 2) | Patients (n = 4) | P-value |
---|---|---|---|
Male [n (%)] | 2 (100%) | 4 (100%) | _★ |
Age (years) | 62 ± 4 | 66 ± 5 | 0.21 |
Age range (years) | 55- 72 | 59- 78 | |
White Caucasian [n (%)] | 2 (100%) | 4 (100%) | _★ |
DM [n (%)] | 0 (0%) | 0 (0%) | _★ |
Hypertension [n (%)] | 0 (0%) | 3 (75%) | 0.4 |
Statin treatment [n (%)] | 0 (0%) | 3 (75%) | 0.4 |
BMI (kg/m2) | 30 ± 1.8 | 28.3 ± 2.8 | 0.35 |
Heart Rate | 68 ± 13 | 64 ± 7 | 0.64 |
SBP (mmHg) | 131 ± 1 | 129 ± 8 | 0.48 |
DBP (mmHg) | 79 ± 1 | 68 ± 14 | 0.35 |
PP (mmHg) | 53 ± 2 | 61 ± 21 | 0.64 |
MAP (mmHg) | 96 ± 1 | 88 ± 7 | 0.35 |
Height (cm) | 183 ± 5 | 176 ± 3 | 0.06 |
Weight (kg) | 101 ± 11 | 90 ± 12 | 0.16 |
PVD [n (%)] | 0 (0%) | 0 (0%) | _★ |
Marfan’s syndrome | 0 (0%) | 0 (0%) | _★ |
Bicuspid aortic valve | 0 (0%) | 1 (25%) | _★ |
NYHA (pre-op.) [n (%)] | 0.46 | ||
Class I | 2 (100%) | 2 (50%) | |
Class II | 0 (0%) | 2 (50%) | |
NYHA (post-op.) [n (%)] | _★ | ||
Class I | 2 (100%) | 4 (100%) | |
Class II | 0 (0%) | 0 (0%) | |
Operative characteristics | |||
Indication for surgery, dilated aortic root and | |||
Aortic stenosis | 1 (25%) | ||
Aortic regurgitation | 2 (50%) | ||
Aortic stenosis and regurgitation | 1 (25%) | ||
Elective | 4 (100%) | ||
CPB time (minutes) | 190 ± 51 | ||
Inotropes [n (%)] | 4 (100%) | ||
Atrial Fibrillation [n (%)] | 4 (100%) | ||
Blood products | 4 (100%) | ||
> 24 intubation | 2 (50%) | ||
Hospital stay (days) | 10.5 ± 2.6 |